← Leaderboards
Michael B Rothberg
Baystate Medical Center, Inc.
$12,358,442
Attributed
$14,573,017
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2010–25$5M$3.8M$2.5M$1.3M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
AHRQ$8,593,803 · 5
NIH$5,979,214 · 1
By mechanism
R01$14,573,017 · 6
Top collaborators
- Abhishek Deshpande5 shared
- Srinivasan Dasarathy4 shared
- Arthur J Mccullough1 shared
Others in their field
Top investigators on “Falls”
- Lawrence Corey · Fred Hutchinson Cancer Center$207,121,712
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$103,177,619
- Marco Pahor · Wake Forest University Health Sciences$82,955,602
- Anders Ryd · Cornell University$79,389,944
- Philip M Tuts · Columbia University$75,152,208
- Eric S Lander · Whitehead Institute For Biomedical Res$71,530,862
Research focus
FallsEffectiveness Of InterventionsAcuteAdultAcute CareAccelerometerBed RestAdoptedCare EpisodeCharacteristicsCostCost MeasuresCovid-19Covid-19 PandemicDeconditioningDecubitus UlcerCare CostsDeliriumDiscipline Of NursingDoseEconomic EvaluationEconomic ImpactEffectivenessFunctional Decline
Grant awards (25)
Randomized Trial of Assisted Ambulation to Improve Health Outcomes for Older Medical Inpatients$1,640,045
R01 · FY2025 · AG · contact PI
Reducing Antimicrobial Overuse Through Targeted Therapy for Patients with Community-Acquired Pneumonia$500,000
R01 · FY2025 · HS · contact PI
Randomized Trial of Assisted Ambulation to Improve Health Outcomes for Older Medical Inpatients$1,632,009
R01 · FY2024 · AG · contact PI
Reducing Antimicrobial Overuse Through Targeted Therapy for Patients with Community-Acquired Pneumonia$500,000
R01 · FY2024 · HS · contact PI
Modeling the Disease Burden and Cost-Effectiveness of Screening and Treatment for Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes Patients$367,899
R01 · FY2024 · HS · contact PI
Randomized Trial of Assisted Ambulation to Improve Health Outcomes for Older Medical Inpatients$1,648,031
R01 · FY2023 · AG · contact PI
Reducing Antimicrobial Overuse Through Targeted Therapy for Patients with Community-Acquired Pneumonia$500,000
R01 · FY2023 · HS · contact PI
Modeling the Disease Burden and Cost-Effectiveness of Screening and Treatment for Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes Patients$384,387
R01 · FY2023 · HS · contact PI
Randomized Trial of Assisted Ambulation to Improve Health Outcomes for Older Medical Inpatients$1,059,129
R01 · FY2022 · AG · contact PI
Reducing Antimicrobial Overuse Through Targeted Therapy for Patients with Community-Acquired Pneumonia$500,000
R01 · FY2022 · HS · contact PI
Modeling the Disease Burden and Cost-Effectiveness of Screening and Treatment for Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes Patients$389,221
R01 · FY2022 · HS · contact PI
Reducing Antimicrobial Overuse Through Targeted Therapy for Patients with Community-Acquired Pneumonia$499,999
R01 · FY2021 · HS · contact PI
Modeling the Disease Burden and Cost-Effectiveness of Screening and Treatment for Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes Patients$389,092
R01 · FY2021 · HS · contact PI
Modeling the Disease Burden and Cost-Effectiveness of Screening and Treatment for Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes Patients$398,552
R01 · FY2020 · HS · contact PI
Reducing Antimicrobial Overuse in HCAP Through Personalized Antimicrobial Recommendations$478,332
R01 · FY2019 · HS · contact PI
Reducing Antimicrobial Overuse in HCAP Through Personalized Antimicrobial Recommendations$496,661
R01 · FY2018 · HS · contact PI
Reducing Antimicrobial Overuse in HCAP Through Personalized Antimicrobial Recommendations$498,112
R01 · FY2017 · HS · contact PI
Patient-Centered approach to reducing harm from VTE$249,134
R01 · FY2017 · HS · contact PI
Reducing Antimicrobial Overuse in HCAP Through Personalized Antimicrobial Recommendations$496,790
R01 · FY2016 · HS · contact PI
Patient-Centered approach to reducing harm from VTE$249,718
R01 · FY2016 · HS · contact PI
Reducing Antimicrobial Overuse in HCAP Through Personalized Antimicrobial Recommendations$499,650
R01 · FY2015 · HS · contact PI
Patient-Centered approach to reducing harm from VTE$247,192
R01 · FY2015 · HS · contact PI
Patient-Centered approach to reducing harm from VTE$247,071
R01 · FY2014 · HS · contact PI
Quality of Care and Outcomes of Healthcare-Associated Pneumonia$321,220
R01 · FY2011 · HS · contact PI
Quality of Care and Outcomes of Healthcare-Associated Pneumonia$380,773
R01 · FY2010 · HS · contact PI